FIGO Stage Is the Strongest Prognostic Factor in Adenocarcinoma of the Uterine Cervix.

[1]  Jacques Balayla,et al.  Study Designs and the Use of the Canadian Task Force Classification. , 2018, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[2]  J. Melnikow,et al.  Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force , 2018 .

[3]  Hongyang Lu,et al.  Adenosquamous carcinoma of the lung , 2018, OncoTargets and therapy.

[4]  M. Köbel,et al.  Cervical Adenocarcinoma: A Comparison of the Reproducibility of the World Health Organization 2003 and 2014 Classifications , 2018, Journal of lower genital tract disease.

[5]  B. Monk,et al.  Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). , 2015, The Lancet. Oncology.

[6]  L. Mariani,et al.  The Role of Lymphadenectomy in Cervical Cancer Patients: The Significance of the Number and the Status of Lymph Nodes Removed in 526 Cases Treated in a Single Institution , 2013, Annals of Surgical Oncology.

[7]  G. Thomas,et al.  Adenocarcinoma: a unique cervical cancer. , 2010, Gynecologic oncology.

[8]  V. Beral,et al.  Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies , 2006, International journal of cancer.

[9]  Xavier Castellsagué,et al.  Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. , 2006, Journal of the National Cancer Institute.

[10]  W. Hop,et al.  Prognostic factors in adenocarcinoma of the uterine cervix. , 2004, Gynecologic oncology.

[11]  J. Carlson,et al.  Adenosquamous histology predicts a poor outcome for patients with advanced‐stage, but not early‐stage, cervical carcinoma , 2003, Cancer.

[12]  C. Key,et al.  The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study. , 2000, Gynecologic oncology.

[13]  W. McCluggage,et al.  Glandular lesions of the uterine cervix , 2000 .

[14]  B. Meunier,et al.  Prognostic factors of the uterine cervix adenocarcinoma. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[15]  C. Drescher,et al.  Adenocarcinoma of the uterine cervix metastatic to lymph nodes. , 1998, American journal of obstetrics and gynecology.

[16]  F. Landoni,et al.  Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer , 1997, The Lancet.

[17]  L. Delclos,et al.  Early stage I adenocarcinoma of the uterine cervix: Treatment results in patients with tumors ≤4 cm in diameter , 1991 .

[18]  K. Hatch,et al.  Analysis of prognostic features in adenocarcinoma of the cervix. , 1988, Gynecologic oncology.